MARSHFIELD ASSOCIATES Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0000914976
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2024 · 18 positions · Total reported value $4.61B · Top-10 concentration 76.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 94.4% · 1 new · 15 cut · 1 exited
Active Share (vs S&P 500): 96.6% · vs QQQ: 99.2% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +8.3% · vs SPY -6.5% · Prev Value $4.99B — last quarter positions weighted by this quarter price moves · ranking
In its Q4 2024 13F filing, MARSHFIELD ASSOCIATES disclosed 18 equity positions with a combined reported value of $4.61B. The filing implies a focused portfolio: its ten largest positions account for 76.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Consumer Tilt / High Turnover.
The largest disclosed positions as of Q4 2024 were ROST ($592.16M), AZO ($545.24M), CMI ($364.95M). By sector, the heaviest allocations are Consumer Discretionary 68.8%, Financials 14.9%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+2.7pp) and away from Financials (-2.9pp).
Versus the prior quarter, MARSHFIELD ASSOCIATES opened 1 new positions, trimmed 15 and fully exited 1, a turnover rate of 94.4% of positions. The portfolio's overlap with the prior quarter was 95% of names.
Of the 1 positions fully exited versus the prior quarter, the largest were USFR ($371.93K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2024)
No new positions this quarter.
Fully Exited (vs previous quarter)
- USFR WISDOMTREE TR · prev qtr: $371.93K
Insider Transactions (Form 4)
Latest MARSHFIELD ASSOCIATES buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Marshfield Associates, based in Washington, DC, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 17 positions worth $4.26B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: WASHINGTON, DC, United States
- SEC registration: 801-70275 (status: Approved), registered 2009-06-24
- Regulatory AUM (Form ADV): $8.11B as of 2026-07-10
- Client mix (by RAUM): individual investors 62%, registered investment companies 17%
Portfolio Structure
- 17 positions · $4.26B reported value (Q2 2026)
- Top 10 holdings = 79.7% of reported value
- Largest position: UNH (UNITEDHEALTH GROUP INC) at 14.9%
- Average position size: $250.87M
Sector Tilt
- Consumer Discretionary 55.1%
- Financials 23.1%
- Health Care 14.9%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 1 new, 1 added, 15 reduced, 1 exited
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
3.91M | $592.16M | 12.83% | Hold | |
| 2 |
|
170.28K | $545.24M | 11.82% | Hold | |
| 3 |
|
1.05M | $364.95M | 7.91% | Hold | |
| 4 |
|
306.32K | $363.23M | 7.87% | Add | |
| 5 |
|
715.42K | $300.30M | 6.51% | Hold | |
| 6 |
|
933.78K | $295.11M | 6.40% | Hold | |
| 7 |
|
556.66K | $293.12M | 6.35% | Add | |
| 8 |
|
2.26M | $273.05M | 5.92% | Reduce | |
| 9 |
|
511.12K | $241.95M | 5.24% | Hold | |
| 10 |
|
2.56M | $236.85M | 5.13% | Reduce | |
| 11 |
|
873.25K | $209.24M | 4.54% | Hold | |
| 12 |
|
1.83M | $202.45M | 4.39% | Add | |
| 13 |
|
23.58K | $192.87M | 4.18% | Hold | |
| 14 |
|
1.59M | $177.30M | 3.84% | Hold | |
| 15 |
|
1.84M | $171.56M | 3.72% | Hold | |
| 16 |
|
1.96M | $141.06M | 3.06% | Reduce | |
| 17 |
|
133.97K | $12.25M | 0.27% | Add | |
| 18 |
|
26.87K | $1.56M | 0.03% | Hold | |
FAQ
What did MARSHFIELD ASSOCIATES buy in 2024-Q4?
In its 2024-Q4 13F filing, MARSHFIELD ASSOCIATES reported 18 equity positions worth $4.61B in aggregate; its largest disclosed positions were ROST ($592.16M), AZO ($545.24M), CMI ($364.95M).
How large is MARSHFIELD ASSOCIATES's portfolio?
MARSHFIELD ASSOCIATES reported $4.61B of long equity holdings across 18 positions as of 2024-Q4. Top-10 holdings account for 76.0% of reported value.
What is MARSHFIELD ASSOCIATES's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Consumer Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.